Onychomycosis Forecast for 2018-2028 with Focus on 22 Markets – ResearchAndMarkets.com

PThe “Epiomic
Epidemiology Series: Onychomycosis Forecast In 22 Major Markets
2018-2028” report has been added to ResearchAndMarkets.com’s
offering.

This report provides the current prevalent population for Onychomycosis
across 22 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK,
Poland, Netherlands, Sweden, Denmark, Finland, Russia, Turkey, Japan,
China, South Korea, India, Australia, Brazil, Mexico, Argentina) split
by gender and 5-year age cohort. Along with the current prevalence, the
report also contains a disease overview of the risk factors and
prevention, disease diagnosis and prognosis along with specific
variations by geography and ethnicity.

Providing a value-added level of insight from our analysis team, patient
groups divided by disease classification, aetiology, main symptoms and
co-morbidities have been quantified and presented alongside the overall
prevalence figures. These sub-populations within the main disease are
also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Onychomycosis include:

Reasons to buy

Key Topics Covered:

For more information about this report visit https://www.researchandmarkets.com/research/75ffjj/onychomycosis?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180712005574/en/

Leave a Comment